Clinical Trial Update: Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex [Phase 4]

View source ↗

Summary

A Phase 4 trial compares ocular tolerance and intraocular pressure between Zylet and Tobradex in eye inflammation. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ophthalmic Inflammation

Drugs mentioned

• Tobradex (tobramycin and dexamethasone)
• Zylet (loteprednol etabonate and tobramycin)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Inflammation | Phase 4 | Status: COMPLETED